MLMIC’s Q2 financials show continued strength and stability for New York’s leading medical liability insurer. In a consistently challenging insurance marketplace, it is reassuring to know that MLMIC is sound and ready to serve its policyholders.
MLMIC has always recognized that eligible policyholders have the right outside the plan of conversion to assign their right to receive their allocable share of the cash consideration. MLMIC will honor any properly drafted and signed assignments that it receives from eligible policyholders on a timely basis.
Clarification of the Description of the Extraordinary Dividend in the Policyholder Information Statement
In the proposed transaction with Berkshire Hathaway, MLMIC announces an important clarification on the description of the extraordinary dividend to NICO.
MLMIC has released a new edition of The Albany Report to help physicians, dentists and other healthcare providers understand the impact of the most recent Legislative session on their practice in New York State.